Preview

Clinical Medicine (Russian Journal)

Advanced search

Сauses, risk factors, diagnostics and treatment of gastrointestinal bleeding in patients with a novel coronavirus infection (COVID-19)

https://doi.org/10.30629/0023-2149-2022-100-7-8-341-345

Abstract

The article discusses the pathogenetic and clinical aspects of gastrointestinal bleeding (GIB) in patients with a novel coronavirus infection (COVID-19). The possibility of direct interaction of the coronavirus with the receptors of the angiotensinconverting enzyme 2 (ACE-2) of the mucous membrane of the gastrointestinal tract with the development of its damage and subsequent bleeding has been shown. The value of anticoagulant therapy as a risk factor for the occurrence of GIB is evaluated inconsistently. In most patients with COVID-19 infection and GIB conservative hemostatic therapy is eff ective. The infl uence of GIB on the course and prognosis of a novel coronavirus infection has an contradictory interpretation. Given the lack of knowledge of the pathogenetic and clinical aspects of GIB in patients with COVID-19 infection, this problem requires further research.

About the Authors

A. A. Sheptulin
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation

Sheptulin Arkadiy A.

119991, Moscow



S. S. Kardasheva
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation

Kardasheva Svetlana S.

119991, Moscow



A. A. Kurbatova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation

Kurbatova Anastasia A.

119991, Moscow



References

1. Mauro A., De Grazua F., Lenti M.V., Penagini R., Frego R., Ardizzone S. et al. Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy. Clin. Res. Hepatol. Gastroenterol. 2021;45(3):101521. DOI: 10.1016/j.clinre.2020.07.025

2. Makker J., Mantri N., Patel H.K., Abbas H., Baiomi A., Sun H. et al. The incidence and mortality impact of gastrointestinal bleeding in hospitalized COVID-19 patients. Clin. Exp. Gastroenterol. 2021;14:405–411. DOI: 10.2147/CEG.S318149

3. Zellmer S., Hanses F., Muzalyova A., Classen J., Braun G., Piepel C. et al. Gastrointestinal bleeding and endoscopic fi ndings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries. United European Gastroenterol J. 2021;9(9):1081–1090. DOI: 10.1002/ueg2.12165

4. Gonzales R., Jacob J., Miro O., Llorens P., Jimenez S., Gonzales Del Catillo J. et al. Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19: Results of the UMC-19-S12. J. Clin. Gastroenterol. 2022;56(1):e38–e46. DOI: 10.1097/MCG.0000000000001465 5. Ashktorab H., Russo T., Dskrochi G., Latella G., Massironi S., Luca M. et al. Clinical and endoscopic outcomes in COVID-19 patients with gastrointestinal bleeding. Gastro. Hep. Adv. 2022;10. DOI: 10.1016/j.gastha.2022.02.021

5. Ierardi A.M., Coppola A., Tortora S. Valconi E., Piacentino F., Fontana F. et al. Gastrointestinal bleeding in patients with SARSCoV-2 infection managed by interventional radiology. J. Clin. Med. 2021;10(20):4758. DOI: 10.3390/jcm10204758

6. Marasco G., Maida M., Morreale G.C. Licata M., Renzulli M., Cremon C. et al. Gastrointestinal bleeding in COVID-19 patients: A systematic review with meta-analysis. Can. J. Gastroenterol. Hepatol. 2021;2021:2534975. DOI: 10.1155/2021/2534975

7. Goyal H., Sachdeva S., Perisetti A., Mann R., Chandan S., Inamdart S. et al. Management of gastrointestinal bleeding during COVID-19: less is more! Eur. J. Gastroenterol. Hepatol. 2021;33(9):1230–1232. DOI: 10.1097/MEG.0000000000002224

8. Massironi S., Vigano C., Dioscoridi L., Filippi E., Pagliorulo M., Manfredi G. et al. Findings in patients infected with 2019 novel coronavirus in Lombardy, Italy. Clin. Gastroenterol. Hepatol. 2020;18(10):2375–2377. DOI: 10.1016/j.cgh.2020.05.045

9. Igbal U., Anwar H., Siddiqui H.U., Khan V.A., Kamal F., Confer B.D., Khara H.S. Acute gastrointestinal bleeding in COVID-19 patients: A systematic review and meta-analysis. Clin. Endosc. 2021;54(4):534– 541. DOI: 10.5946/ce.2021.071

10. Trindade A.J., Izard S., Coppa K., Hirsch J.S., Lee C., Satapathy S.K. Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study. J. Intern. Med. 2021;289(6):887–894. DOI: 10.1111/joim.13232

11. Rustgi S.D., Yang J.Y., Luthrt S., David Y., Dixon R.E., Simoes P.K. et al. Anticoagulation does not increase risk of mortality or ICU admission in hospitalized COVID-19 patients with gastrointestinal bleeding: Results from a New York health system. Clin. Res. Hepatol Gastroenterol. 2021;45(3):101602. DOI: 10.1016/j.clinre.2020.101602

12. Zhao X., Tao M., Chen C., Zhang Y., Fu Y. Clinical features and factors associated with occult gastrointestinal bleeding in COVID-19 patients. Infect. Drug Resist. 2021;14:4217–4226. DOI: 10.2147/IDR.S335868

13. Martin T.A., Wan D.W., Hajifatalian K., Temani S., Shah S.L., Mehta A. et al. Gastrointestinal bleeding in patients with coronavirus disease 2019: A matched case-control study. Am. J. Gastroenterol. 2020;115(10):1609–1616. DOI: 10.14309/ajg.0000000000000805

14. Vanella G., Capurso G., Burti C., Fanto L., Ricciardiello L., Lino A.S. et al. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol. 2021;8(1):e000578. DOI: 10.1136/bmjgast-2020-000578

15. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020:S0016-5085(20)30282-1. DOI:10.1053/j.gastro.2020.02.055

16. Gadiparthi C., Perisetti A., Sayana H.,Tharian B., Inamdar S., Korman A. Gastrointestinal bleeding in patients with severe SARS CoV-2. Am. J. Gastroenterol. 2020;115(8):1283–1285. DOI: 10.14309/ajg.0000000000000719

17. Li X., Huang S., Lu J., Lai R., Zhang Z., Lin X. et al. Upper gastrointestinal bleeding caused by SARS-CoV-2 Infection. Am. J. Gastroenterol. 2020;115(9):1541–1542. DOI: 10.14309/ajg.0000000000000757

18. Awwad I., Greuel S., Tacke F., Fischer C. Haemorrhagic ulcerative duodenitis in a patient with COVID-19 infection: clinical improvement following treatment with budesonide. BMJ Open Gastroenterol. 2021;8(1):e000757. DOI: 10.1136/bmjgast-2021-000757

19. Lacavalla D., Santandrea G., Andreotti D., Stano R., Occhionorelli S. Case report of gastrointestinal localization of SARS-CoV-2 and open abdomen technique in an Italian emergency surgery department for gastrointestinal bleeding. Ann. Med. Surg. (Lond). 2021;66:102405. DOI: 10.1016/j.amsu.2021.102405

20. Stahl K., Bräsen J.H., Hoeper M.M., David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020;46(11):2081–2082. DOI:10.1007/s00134-020-06237-6

21. Melazzini F., Lento M.V., Mauro A. De Grazia F., Di Sabatino A. Peptic ulcer disease as a common cause of bleeding in patients with coronavirus disease 2019. J. Gastroenterol. 2020;115(7):1139–1140. DOI: 10.14309/ajg.0000000000000710

22. Perez Roldan F., Malik Javed Z., Yague Compadre J.L., Navarro Lopez M.D.K. Rodriguez-Bobado Caraballo D., Fernandez Visier I. et al. Gastric ulcers with upper gastrointestinal bleeding in patients with severe SARS-CoV-2. Rev. Esp. Enferm. Dig. 2021;113(2):122– 124. DOI: 10.17235/reed.2021.7759/2020

23. Buckholz A., Kaplan A., Jessurun J., De Jong Y., Crawford C. Microthrombosis associated with GI bleeding in COVID-19. Gastrointest. Endosc. 2021;93(1):263–264. DOI: 10.1016/j.gie.2020.07.010

24. Amarapurkar A.D., Vichare P., Pandya N., Deshpande S. Haemorrhagic enteritis and COVID-19: causality or coincidence. J. Clin. Pathol. 2020;73(10):686. DOI: 10.1136/jclinpath-2020-206743

25. Khatib M.Y., Shaik K.S., Ahmed A.A., Alwraidat M.A., Mohamed A.S., Abou Kamar M.R. et al. Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19. Clin. Case Rep. 2020;9(1):148–152.DOI: 10.1002/ccr3.3487

26. Carvalho A., Alqusairi R., Adams A., Paul M., Kothari N., Peters S. et al. SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Am. J. Gastroenterol. 2020;115(6):942–946. DOI: 10.14309/ajg.0000000000000667

27. Cavaliere K., Levine C., Trindade A.J. Management of upper GI bleeding in patients with COVID-19 pneumonia. Gastrointest. Endosc. 2020;92(2):454–455. DOI: 10/1016/j.gie.2020.04.028

28. Sharma S., Kumar R., Shalimar. Management of gastrointestinal bleeding in coronavirus disease: exploring the options. Am. J. Gastroenterol. 2021;116(4):843–844. DOI: 10.14309/ajg.0000000000000979

29. Shalimar, Vaishnav M., Elhence A., Kumar R., Mohta S., Palle C. et al. Outcome of conservative therapy in coronavirus disease-2019 patients presenting with gastrointestinal bleeding. J. Clin. Exp. Hepatol. 2021;11(3):327–333. DOI: 10.1016/j.jceh.2020.09.007

30. Lan L., Yang L., Li J., Shen Z., Zhang B. Diagnosis of suspected small bowel bleeding by capsule endoscopy in patients with COVID-19. Intern Med. 2021;60(15):2425–2430. DOI: 10.2169/internalmedicine.7235-21

31. Chen H., Tong Z., Ma Z., Luo L., Tang Y., Teng Y. et al. Gastrointestinal bleeding, but not other gastrointestinal symptoms, is associated with worse outcomes in COVID-19 patients. Front Med. (Lausanne). 2021;8:759152. DOI: 10.3389/fmed.2021.759152

32. Tavabie O.D., Clough J.N., Blackwell J., Bashyam M., Martin H., Soubieres A. et al. Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary eff ect of the response to the global pandemic: a retrospective cohort study. Frontline Gastroenterol. 2020;12(4):279–287. DOI: 10.1136/fl gastro-2020-101592


Review

For citations:


Sheptulin A.A., Kardasheva S.S., Kurbatova A.A. Сauses, risk factors, diagnostics and treatment of gastrointestinal bleeding in patients with a novel coronavirus infection (COVID-19). Clinical Medicine (Russian Journal). 2022;100(7-8):341-345. (In Russ.) https://doi.org/10.30629/0023-2149-2022-100-7-8-341-345

Views: 572


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0023-2149 (Print)
ISSN 2412-1339 (Online)